Susquehanna International Group’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$25.6M Buy
45,500
+600
+1% +$385K ﹤0.01% 1920
2025
Q4
$30.4M Sell
44,900
-46,700
-51% -$31.8M ﹤0.01% 1807
2025
Q3
$58.5M Buy
91,600
+40,200
+78% +$24.4M 0.01% 1236
2025
Q2
$27.6M Buy
51,400
+21,100
+70% +$10.1M ﹤0.01% 1681
2025
Q1
$12.7M Sell
30,300
-10,300
-25% -$4.47M ﹤0.01% 2226
2024
Q4
$16.8M Sell
40,600
-19,700
-33% -$8.64M ﹤0.01% 2022
2024
Q3
$30.5M Buy
60,300
+16,300
+37% +$7.92M 0.01% 1455
2024
Q2
$21.4M Sell
44,000
-25,300
-37% -$12.7M ﹤0.01% 1653
2024
Q1
$37.4M Buy
69,300
+9,500
+16% +$5.19M 0.01% 1233
2023
Q4
$33.2M Sell
59,800
-3,900
-6% -$1.83M 0.01% 1333
2023
Q3
$27.9M Sell
63,700
-42,800
-40% -$21.3M 0.01% 1448
2023
Q2
$53.5M Sell
106,500
-26,900
-20% -$12.9M 0.01% 948
2023
Q1
$66.7M Sell
133,400
-62,400
-32% -$29.9M 0.01% 787
2022
Q4
$79.9M Buy
195,800
+99,100
+102% +$38.5M 0.02% 651
2022
Q3
$31.5M Sell
96,700
-12,000
-11% -$4.41M 0.01% 1086
2022
Q2
$38.1M Buy
108,700
+40,800
+60% +$16.6M 0.01% 999
2022
Q1
$37.1M Sell
67,900
-2,900
-4% -$1.53M 0.01% 1188
2021
Q4
$46.6M Sell
70,800
-19,900
-22% -$12.5M 0.01% 1148
2021
Q3
$56.4M Buy
90,700
+26,700
+42% +$17.9M 0.01% 1081
2021
Q2
$40.4M Buy
64,000
+7,900
+14% +$4.36M 0.01% 1360
2021
Q1
$27.5M Buy
56,100
+20,100
+56% +$10.1M ﹤0.01% 1549
2020
Q4
$18M Sell
36,000
-14,000
-28% -$6.26M ﹤0.01% 1852
2020
Q3
$19.7M Sell
50,000
-16,000
-24% -$5.92M ﹤0.01% 1501
2020
Q2
$21.8M Buy
66,000
+20,200
+44% +$5.85M 0.01% 1357
2020
Q1
$11.1M Buy
45,800
+21,600
+89% +$5.64M ﹤0.01% 1631
2019
Q4
$6.32M Sell
24,200
-18,800
-44% -$4.95M ﹤0.01% 2653
2019
Q3
$11.7M Buy
43,000
+9,000
+26% +$2.5M ﹤0.01% 1811
2019
Q2
$9.36M Sell
34,000
-27,200
-44% -$6.7M ﹤0.01% 1947
2019
Q1
$13.7M Sell
61,200
-1,200
-2% -$248K 0.01% 1484
2018
Q4
$11.6M Buy
62,400
+7,200
+13% +$1.48M ﹤0.01% 1477
2018
Q3
$13.8M Sell
55,200
-1,400
-2% -$340K ﹤0.01% 1639
2018
Q2
$12.3M Sell
56,600
-6,900
-11% -$1.42M ﹤0.01% 1725
2018
Q1
$12.2M Buy
63,500
+37,400
+143% +$6.9M ﹤0.01% 1612
2017
Q4
$4.08M Sell
26,100
-13,800
-35% -$2.17M ﹤0.01% 2796
2017
Q3
$6.2M Sell
39,900
-10,200
-20% -$1.61M ﹤0.01% 2253
2017
Q2
$8.09M Buy
50,100
+4,000
+9% +$650K ﹤0.01% 1883
2017
Q1
$7.13M Buy
46,100
+25,300
+122% +$3.49M ﹤0.01% 1978
2016
Q4
$2.44M Buy
20,800
+4,900
+31% +$559K ﹤0.01% 3652
2016
Q3
$1.79M Sell
15,900
-1,800
-10% -$190K ﹤0.01% 3741
2016
Q2
$1.64M Sell
17,700
-9,500
-35% -$816K ﹤0.01% 3921
2016
Q1
$2.13M Buy
27,200
+20,200
+289% +$1.45M ﹤0.01% 3649
2015
Q4
$510K Sell
7,000
-300
-4% -$21.4K ﹤0.01% 6728
2015
Q3
$542K Sell
7,300
-3,900
-35% -$279K ﹤0.01% 6961
2015
Q2
$718K Buy
11,200
+8,400
+300% +$582K ﹤0.01% 6889
2015
Q1
$216K Hold
2,800
﹤0.01% 8524
2014
Q4
$208K Buy
+2,800
New +$196K ﹤0.01% 8757
2014
Q3
Sell
-4,000
Closed -$267K 9648
2014
Q2
$267K Sell
4,000
-12,400
-76% -$788K ﹤0.01% 8581
2014
Q1
$995K Sell
16,400
-5,200
-24% -$310K ﹤0.01% 5532
2013
Q4
$1.15M Sell
21,600
-25,600
-54% -$1.35M ﹤0.01% 5259
2013
Q3
$2.35M Buy
47,200
+28,800
+157% +$1.38M ﹤0.01% 3843
2013
Q2
$826K Buy
+18,400
New +$804K ﹤0.01% 5308

Other funds holding IDXX

Susquehanna International Group's IDXX Position: Q1 2026 in Review

Susquehanna International Group reduced its Idexx Laboratories (IDXX) stake by 30% in Q1 2026, selling an estimated $3.85M and leaving 14,061 shares worth $7.9M. The position accounts for ﹤0.01% of the portfolio, ranked #3482.

Susquehanna International Group first reported a position in IDXX in Q2 2013 and has held it in 47 quarters since. The position peaked at $35.9M in Q2 2021. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Susquehanna International Group held 14,061 shares of Idexx Laboratories worth $7.9M as of Q1 2026.
  • Susquehanna International Group sold 6,003 Idexx Laboratories shares in Q1 2026, an estimated $3.85M.
  • Idexx Laboratories made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #3482 holding.
  • Susquehanna International Group first reported a position in Idexx Laboratories in Q2 2013 and has held it in 47 quarters since.
  • Susquehanna International Group's Idexx Laboratories position peaked at $35.9M in Q2 2021.
  • 1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.